February 1, 2023
FDA: Class I recall of Medtronic Mahurkar Acute Dual Lumen High Flow Hemodialysis Catheters
Editor's Note
The Food and Drug Administration (FDA) on January 30 identified the recall by Medtronic of its Mahurkar Acute Dual Lumen High Flow (13.5 French) Hemodialysis Catheters (Mahurkar QPlus) as Class I, the most serious.
The recall was initiated because of a potential catheter hub defect that may cause leaks across the catheter’s tubes.
There have been reports of two injuries and no deaths related to this issue.
Distribution dates were March 19, 2022, to September 2, 2022.
Free Daily News
- Study explores use of antibiotics as alternative to pediatric appendectomy
- Medical device shortages present pediatric patient challenges, FDA warns
- Expansive study highlights GLP-1 risks, potential beyond weight loss, diabetes treatment
- HHS report highlights cost, access, quality concerns with private equity in healthcare
- Study: Racial, gender disparities persist in bariatric surgery
- Study: Dry eye risks complicate cataract surgery recovery
- Study: Observational learning ineffective in ensuring nursing student infection control compliance
- Students innovate to reduce OR plastic waste
- OR Business Management Conference 2025 features fresh perspectives, new tracks
- Survey: Bariatric surgery’s fertility benefits not widely understood
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement